- Home
- ZNTL vs LSAK Comparison
ZNTL vs LSAK Comparison
Compare ZNTL & LSAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZNTL
- LSAK
- Stock Information
- Founded
- ZNTL 2014
- LSAK 1997
- Country
- ZNTL United States
- LSAK South Africa
- Employees
- ZNTL N/A
- LSAK N/A
- Industry
- ZNTL Biotechnology: Pharmaceutical Preparations
- LSAK Investment Bankers/Brokers/Service
- Sector
- ZNTL Health Care
- LSAK Finance
- Exchange
- ZNTL Nasdaq
- LSAK Nasdaq
- Market Cap
- ZNTL 105.8M
- LSAK 344.5M
- IPO Year
- ZNTL 2020
- LSAK N/A
- Fundamental
- Price
- ZNTL $1.26
- LSAK $4.65
- Analyst Decision
- ZNTL Buy
- LSAK
- Analyst Count
- ZNTL 7
- LSAK 0
- Target Price
- ZNTL $8.60
- LSAK N/A
- AVG Volume (30 Days)
- ZNTL 1.3M
- LSAK 33.8K
- Earning Date
- ZNTL 08-08-2025
- LSAK 05-07-2025
- Dividend Yield
- ZNTL N/A
- LSAK N/A
- EPS Growth
- ZNTL N/A
- LSAK N/A
- EPS
- ZNTL N/A
- LSAK N/A
- Revenue
- ZNTL $26,865,000.00
- LSAK $574,080,000.00
- Revenue This Year
- ZNTL N/A
- LSAK $1.06
- Revenue Next Year
- ZNTL N/A
- LSAK $13.32
- P/E Ratio
- ZNTL N/A
- LSAK N/A
- Revenue Growth
- ZNTL N/A
- LSAK 4.13
- 52 Week Low
- ZNTL $1.01
- LSAK $3.39
- 52 Week High
- ZNTL $5.44
- LSAK $5.60
- Technical
- Relative Strength Index (RSI)
- ZNTL 46.30
- LSAK 66.54
- Support Level
- ZNTL $1.13
- LSAK $4.45
- Resistance Level
- ZNTL $1.39
- LSAK $4.65
- Average True Range (ATR)
- ZNTL 0.11
- LSAK 0.22
- MACD
- ZNTL -0.02
- LSAK 0.06
- Stochastic Oscillator
- ZNTL 32.93
- LSAK 100.00
About ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
About LSAK Lesaka Technologies Inc.
Lesaka Technologies Inc provides payment solutions, transaction processing solutions, and financial technologies. The company operates two reportable segments: Merchant and Consumer. The company operates mainly within South Africa. The Merchant segment that derives majority revenue includes activities related to the provision of goods and services provided to corporate and other juristic entities. It earns fees from processing activities performed for its customers and revenue generated from the distribution of prepaid airtime. The Consumer segment includes activities related to the provision of financial services to customers, including bank accounts, loans, and insurance products. The firm charges monthly administration fees for all bank accounts.